Free Trial

CrossAmerica Partners (CAPL) Financials

CrossAmerica Partners logo
$21.71 +0.39 (+1.83%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$21.70 -0.01 (-0.05%)
As of 05/8/2026 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for CrossAmerica Partners

Annual Income Statements for CrossAmerica Partners

This table shows CrossAmerica Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
10 7.31 19 3.67 18 107 22 62 40 20 39
Consolidated Net Income / (Loss)
11 11 23 5.25 18 107 22 64 43 22 42
Net Income / (Loss) Continuing Operations
11 11 23 5.25 18 107 22 64 43 22 42
Total Pre-Tax Income
7.92 10 4.94 2.51 17 100 18 64 45 19 50
Total Operating Income
15 16 32 35 43 112 36 96 88 71 98
Total Gross Profit
169 156 161 173 155 212 277 376 382 398 403
Total Revenue
2,226 1,870 2,095 2,446 2,149 1,932 3,579 4,967 4,386 4,098 3,663
Operating Revenue
2,226 1,870 2,095 2,446 2,149 1,932 3,579 4,967 4,386 4,098 3,663
Total Cost of Revenue
2,057 1,714 1,934 2,273 1,995 1,720 3,302 4,592 4,004 3,700 3,260
Operating Cost of Revenue
2,057 1,714 1,934 2,273 1,995 1,720 3,302 4,592 4,004 3,700 3,260
Total Operating Expenses
154 139 128 138 126 100 241 280 294 328 305
Selling, General & Admin Expense
108 85 89 80 69 112 165 200 222 257 260
Depreciation Expense
48 54 57 67 55 69 78 81 77 76 90
Other Special Charges / (Income)
-2.72 - - - - -81 -2.04 -1.14 -4.74 -4.97 -44
Total Other Income / (Expense), net
-7.57 -5.86 -27 -32 -12 -13 -18 -32 -43 -52 -48
Interest Expense
18 23 28 33 27 17 18 32 44 52 48
Other Income / (Expense), net
0.40 0.85 0.44 0.37 0.52 0.50 0.54 0.50 0.79 0.78 0.58
Income Tax Expense
-3.54 -0.45 -18 -2.73 -1.23 -7.95 -3.23 0.71 2.53 -3.43 8.25
Preferred Stock Dividends Declared
- - - - - 0.00 0.00 1.73 2.49 2.56 2.72
Basic Earnings per Share
$0.35 $0.22 $0.56 $0.11 $0.51 $2.87 $0.57 $1.63 $1.06 $0.52 $1.03
Weighted Average Basic Shares Outstanding
21.46M 32.16M 33.84M 34.35M 34.45M 37.37M 37.88M 37.92M 37.96M 38.03M 38.10M
Diluted Earnings per Share
$0.35 $0.22 $0.56 $0.11 $0.51 $2.87 $0.57 $1.63 $1.05 $0.52 $1.02
Weighted Average Diluted Shares Outstanding
21.56M 32.22M 33.84M 34.35M 34.48M 37.37M 37.88M 38.06M 38.12M 38.17M 38.25M
Weighted Average Basic & Diluted Shares Outstanding
7.53M 1.15M 33.84M 34.35M 34.45M 37.37M 37.88M 37.92M 37.98M 38.06M 38.14M

Quarterly Income Statements for CrossAmerica Partners

This table shows CrossAmerica Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
12 16 -18 12 10 16 -7.78 24 13 9.51 9.97
Consolidated Net Income / (Loss)
12 17 -18 12 11 17 -7.12 25 14 10 11
Net Income / (Loss) Continuing Operations
12 17 -18 12 11 17 -7.12 25 14 10 11
Total Pre-Tax Income
14 17 -23 14 13 15 -11 29 16 15 13
Total Operating Income
24 27 -13 28 27 28 2.00 41 28 26 24
Total Gross Profit
100 102 81 105 111 101 90 101 105 107 98
Total Revenue
1,210 1,015 942 1,133 1,079 944 862 962 972 866 842
Operating Revenue
1,210 1,015 942 1,133 1,079 944 862 962 972 866 842
Total Cost of Revenue
1,110 913 860 1,029 968 843 773 861 867 759 744
Operating Cost of Revenue
1,110 913 860 1,029 968 843 773 861 867 759 744
Total Operating Expenses
76 75 94 77 84 73 88 59 77 81 74
Selling, General & Admin Expense
57 56 59 64 68 66 67 65 64 65 63
Depreciation Expense
19 19 19 18 21 18 26 23 20 20 17
Other Special Charges / (Income)
-0.29 0.48 17 -5.58 -4.68 -12 -5.04 -28 -7.39 -3.44 -6.12
Total Other Income / (Expense), net
-10 -10 -10 -14 -14 -13 -13 -12 -12 -11 -11
Interest Expense
11 10 11 14 14 13 13 13 12 11 11
Other Income / (Expense), net
0.17 0.19 0.25 0.16 0.20 0.18 0.13 0.14 0.15 0.16 0.16
Income Tax Expense
1.47 -0.08 -5.80 1.70 2.42 -1.76 -3.60 3.90 2.87 5.09 2.50
Preferred Stock Dividends Declared
0.63 0.64 0.66 0.67 0.58 0.65 0.67 0.68 0.70 0.68 0.69
Basic Earnings per Share
$0.31 $0.42 ($0.48) $0.31 $0.27 $0.42 ($0.20) $0.64 $0.34 $0.25 $0.26
Weighted Average Basic Shares Outstanding
37.97M 37.96M 37.99M 38.03M 38.04M 38.03M 38.07M 38.10M 38.11M 38.10M 38.14M
Diluted Earnings per Share
$0.31 $0.42 ($0.48) $0.31 $0.27 $0.42 ($0.20) $0.64 $0.34 $0.24 $0.26
Weighted Average Diluted Shares Outstanding
38.14M 38.12M 37.99M 38.20M 38.20M 38.17M 38.07M 39.55M 38.27M 38.25M 38.30M
Weighted Average Basic & Diluted Shares Outstanding
37.97M 37.98M 38.03M 38.05M 38.05M 38.06M 38.10M 38.12M 38.12M 38.14M 38.15M

Annual Cash Flow Statements for CrossAmerica Partners

This table details how cash moves in and out of CrossAmerica Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-14 0.16 2.55 -0.71 -1.41 -1.27 7.14 8.41 -11 -1.61 -0.24
Net Cash From Operating Activities
64 79 89 90 72 104 95 161 117 88 91
Net Cash From Continuing Operating Activities
64 79 89 90 72 104 95 161 117 88 91
Net Income / (Loss) Continuing Operations
11 11 23 5.25 18 107 22 64 43 22 42
Consolidated Net Income / (Loss)
11 11 23 5.25 18 107 22 64 43 22 42
Depreciation Expense
48 54 57 67 55 69 78 81 77 76 90
Amortization Expense
1.87 1.86 1.78 1.51 1.03 1.04 1.86 2.79 3.29 1.94 1.94
Non-Cash Adjustments To Reconcile Net Income
12 16 12 11 3.26 -88 -4.23 1.38 -1.67 -3.30 -42
Changes in Operating Assets and Liabilities, net
-8.88 -3.65 -5.30 5.76 -5.06 15 -1.67 13 -4.29 -9.29 0.51
Net Cash From Investing Activities
-312 -97 -60 -6.78 -16 -20 -299 -46 -28 -16 68
Net Cash From Continuing Investing Activities
-312 -97 -60 -6.78 -16 -20 -299 -46 -28 -16 68
Purchase of Property, Plant & Equipment
-10 -21 -12 -14 -25 -37 -42 -30 -35 -26 -36
Acquisitions
-310 -97 -76 -0.49 0.00 -28 -273 -30 0.00 0.00 0.00
Sale of Property, Plant & Equipment
6.41 2.68 28 6.64 4.86 45 15 13 6.23 35 104
Sale and/or Maturity of Investments
1.96 18 0.45 0.78 1.10 0.97 0.79 0.20 0.21 0.15 0.12
Other Investing Activities, net
- - - - 3.15 - - 0.00 0.00 -26 0.00
Net Cash From Financing Activities
233 18 -26 -84 -58 -86 210 -107 -100 -73 -160
Net Cash From Continuing Financing Activities
233 18 -26 -84 -58 -86 210 -107 -100 -73 -160
Repayment of Debt
-214 -135 -144 -141 -97 -112 -85 -164 -257 -102 -153
Payment of Dividends
-66 -84 -88 -77 -73 -78 -80 -80 -81 -81 -82
Issuance of Debt
372 215 205 128 114 106 377 115 241 113 78
Issuance of Preferred Equity
- - - - - 0.00 0.00 24 0.00 0.00 0.00
Other Financing Activities, net
- 25 0.33 6.31 -2.30 -2.46 -2.60 -2.72 -2.89 -3.08 -3.26

Quarterly Cash Flow Statements for CrossAmerica Partners

This table details how cash moves in and out of CrossAmerica Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
1.30 -0.80 1.29 -0.79 2.28 -4.38 3.37 2.97 -3.95 -2.63 4.21
Net Cash From Operating Activities
32 38 5.82 29 42 11 15 23 24 29 28
Net Cash From Continuing Operating Activities
32 38 5.82 29 42 11 15 23 24 29 28
Net Income / (Loss) Continuing Operations
12 17 -18 12 11 17 -7.12 25 14 10 11
Consolidated Net Income / (Loss)
12 17 -18 12 11 17 -7.12 25 14 10 11
Depreciation Expense
19 19 19 18 21 18 26 23 20 20 17
Amortization Expense
0.48 0.48 0.48 0.49 0.48 0.49 0.49 0.48 0.48 0.49 0.48
Non-Cash Adjustments To Reconcile Net Income
0.67 1.43 17 -5.13 -4.12 -11 -4.22 -28 -7.02 -2.94 -5.89
Changes in Operating Assets and Liabilities, net
-0.82 0.49 -13 2.68 14 -13 -0.40 1.85 -2.71 1.78 5.56
Net Cash From Investing Activities
-9.85 -12 -26 -0.15 -0.45 10 -1.34 52 15 2.22 7.84
Net Cash From Continuing Investing Activities
-9.85 -12 -26 -0.15 -0.45 10 -1.34 52 15 2.22 7.84
Purchase of Property, Plant & Equipment
-10 -13 -6.11 -5.31 -7.72 -7.19 -10 -12 -6.70 -7.07 -3.43
Acquisitions
- - - - - - 0.00 - - - -1.80
Sale of Property, Plant & Equipment
0.45 1.25 0.00 11 7.24 17 8.75 64 22 9.26 13
Sale and/or Maturity of Investments
0.06 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02
Other Investing Activities, net
- - -20 -5.61 - - 0.00 - - - 0.00
Net Cash From Financing Activities
-21 -27 21 -30 -39 -26 -10 -72 -44 -34 -32
Net Cash From Continuing Financing Activities
-21 -26 21 -30 -39 -26 -10 -72 -44 -34 -32
Repayment of Debt
-15 -26 -6.81 -30 -38 -27 -19 -63 -30 -42 -35
Payment of Dividends
-21 -19 -20 -20 -21 -20 -20 -20 -21 -20 -20
Issuance of Debt
16 19 49 21 21 22 29 12 8.00 29 25
Other Financing Activities, net
-0.73 -0.74 -0.74 -0.77 -0.78 -0.79 -0.79 -0.81 -0.83 -0.83 -1.12

Annual Balance Sheets for CrossAmerica Partners

This table presents CrossAmerica Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
861 932 947 867 911 1,014 1,270 1,257 1,182 1,115 965
Total Current Assets
58 65 81 51 69 75 106 118 109 119 111
Cash & Equivalents
1.19 1.35 3.90 3.19 1.78 0.51 7.65 16 4.99 3.38 3.14
Accounts Receivable
33 42 42 26 42 29 34 32 32 32 29
Inventories, net
16 13 15 14 6.23 23 46 47 52 63 60
Other Current Assets
4.94 6.56 7.53 5.51 5.80 12 13 22 19 11 9.39
Other Current Nonoperating Assets
3.29 2.11 12 2.22 13 9.90 4.91 0.98 0.40 8.99 9.69
Plant, Property, & Equipment, net
629 677 681 647 566 571 755 728 705 656 548
Total Noncurrent Assets
175 189 186 169 276 369 405 408 368 340 306
Goodwill
81 89 89 89 89 89 100 99 99 99 99
Intangible Assets
82 81 76 59 45 93 114 114 95 77 62
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - 0.76 1.00 0.76
Other Noncurrent Operating Assets
12 19 21 21 142 187 191 194 173 162 144
Total Liabilities & Shareholders' Equity
861 932 947 867 911 1,014 1,270 1,257 1,182 1,115 965
Total Liabilities
593 711 776 756 833 905 1,214 1,178 1,151 1,140 1,037
Total Current Liabilities
75 75 93 88 113 147 164 175 161 163 150
Short-Term Debt
7.61 2.10 2.92 2.30 2.47 2.63 11 11 3.08 3.27 3.47
Accounts Payable
41 45 61 58 58 69 75 85 79 82 70
Accrued Expenses
17 16 17 18 16 23 21 23 24 24 27
Other Taxes Payable
- 12 12 11 12 20 23 21 20 19 19
Other Current Liabilities
- - - 0.00 23 32 35 35 35 35 30
Total Noncurrent Liabilities
518 636 683 668 799 758 1,050 1,003 986 977 887
Long-Term Debt
404 465 529 - - - 811 762 754 764 687
Capital Lease Obligations
- - - 519 535 527 - - - 106 97
Asset Retirement Reserve & Litigation Obligation
23 28 31 33 36 41 45 46 48 48 45
Noncurrent Deferred & Payable Income Tax Liabilities
44 43 24 20 19 15 12 13 13 7.42 7.41
Other Noncurrent Operating Liabilities
47 100 98 96 209 174 181 182 172 51 51
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 0.00 26 28 29 30
Total Equity & Noncontrolling Interests
269 221 171 111 0.00 110 57 53 3.01 -54 -102
Total Preferred & Common Equity
269 221 171 111 0.00 110 57 53 3.01 -54 -102
Total Common Equity
269 221 171 111 0.00 110 57 53 3.01 -54 -102
Common Stock
269 221 171 111 - 112 54 37 -2.39 -61 -101
Accumulated Other Comprehensive Income / (Loss)
- - - - 0.00 -2.46 3.03 16 5.40 7.60 -1.05

Quarterly Balance Sheets for CrossAmerica Partners

This table presents CrossAmerica Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
1,247 1,224 1,218 1,217 1,179 1,165 1,130 1,087 1,028 999 1,003
Total Current Assets
123 111 116 123 123 126 126 151 125 117 125
Cash & Equivalents
12 7.52 4.49 5.79 6.28 5.49 7.77 6.75 9.72 5.77 7.35
Accounts Receivable
34 29 35 39 36 39 33 29 33 35 32
Inventories, net
47 48 52 54 58 64 61 61 59 61 65
Other Current Assets
22 25 23 24 18 15 13 13 9.28 9.93 13
Other Current Nonoperating Assets
7.10 2.01 1.00 1.14 4.64 2.49 12 42 14 6.12 7.73
Plant, Property, & Equipment, net
738 717 709 706 693 685 665 606 587 569 589
Total Noncurrent Assets
386 394 392 388 363 354 339 329 317 313 288
Goodwill
99 99 99 99 99 99 99 99 99 99 99
Intangible Assets
95 108 103 99 90 86 82 73 69 65 58
Noncurrent Deferred & Refundable Income Taxes
- - - - 1.43 0.82 0.08 1.76 1.91 1.38 0.56
Other Noncurrent Operating Assets
191 187 189 190 172 168 158 154 146 147 130
Total Liabilities & Shareholders' Equity
1,247 1,224 1,218 1,217 1,179 1,165 1,130 1,087 1,028 999 1,003
Total Liabilities
1,164 1,168 1,162 1,168 1,181 1,173 1,161 1,143 1,083 1,061 1,081
Total Current Liabilities
176 157 170 177 160 165 173 164 162 164 168
Short-Term Debt
8.38 2.94 38 38 3.13 3.18 38 38 37 38 9.81
Accounts Payable
89 75 86 90 78 83 89 81 80 79 85
Accrued Expenses
23 24 25 28 25 24 26 26 25 29 29
Other Taxes Payable
21 20 21 21 19 20 19 18 19 19 19
Other Current Liabilities
35 35 - - 35 35 0.22 0.15 0.25 0.48 26
Total Noncurrent Liabilities
988 1,011 992 991 1,020 1,007 988 979 920 897 913
Long-Term Debt
752 777 760 761 796 787 769 774 723 701 726
Capital Lease Obligations
- - 127 123 - - 108 102 95 95 86
Asset Retirement Reserve & Litigation Obligation
46 47 47 48 48 49 49 48 46 45 45
Noncurrent Deferred & Payable Income Tax Liabilities
12 8.53 11 12 7.65 7.88 7.47 4.88 6.02 5.27 7.19
Other Noncurrent Operating Liabilities
177 178 46 47 169 164 55 50 50 50 49
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
26 27 27 27 28 29 28 30 30 30 31
Total Equity & Noncontrolling Interests
57 29 28 22 -30 -37 -59 -86 -84 -92 -109
Total Preferred & Common Equity
57 29 28 22 -30 -37 -59 -86 -84 -92 -109
Total Common Equity
57 29 28 22 -30 -37 -59 -86 -84 -92 -109
Common Stock
40 15 9.22 1.23 -40 -48 -57 -89 -84 -91 -111
Accumulated Other Comprehensive Income / (Loss)
17 14 19 21 9.40 11 -1.63 2.75 -0.17 -0.72 1.57

Annual Metrics And Ratios for CrossAmerica Partners

This table displays calculated financial ratios and metrics derived from CrossAmerica Partners' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.46% -16.01% 12.03% 16.76% -12.14% -10.08% 85.23% 38.78% -11.70% -6.57% -10.63%
EBITDA Growth
45.31% 11.01% 25.75% 12.31% -3.42% 82.85% -36.29% 54.59% -5.90% -11.84% 27.13%
EBIT Growth
74.45% 6.84% 93.61% 7.69% 23.91% 157.48% -67.52% 163.16% -7.93% -19.72% 37.69%
NOPAT Growth
270.64% -24.90% 803.64% -51.95% -36.40% 161.09% -65.02% 123.65% -12.43% 0.19% -2.09%
Net Income Growth
285.74% -6.52% 116.29% -77.36% 244.57% 494.47% -79.85% 194.15% -33.13% -47.28% 86.31%
EPS Growth
209.38% -37.14% 154.55% -80.36% 363.64% 462.75% -80.14% 185.96% -35.58% -50.48% 96.15%
Operating Cash Flow Growth
126.02% 23.19% 11.98% 0.89% -19.41% 44.46% -8.63% 68.97% -27.42% -25.03% 4.23%
Free Cash Flow Firm Growth
-56.15% 104.04% 1,773.70% -10.55% 13.33% -90.41% -1,417.49% 165.70% 3.10% 7.28% 572.91%
Invested Capital Growth
48.11% 1.31% 0.42% -8.78% -16.71% 20.46% 37.11% -3.54% -5.56% -7.06% -16.65%
Revenue Q/Q Growth
-5.25% 1.83% 2.50% -0.22% -1.62% 2.08% 17.24% 0.96% -2.45% -1.69% -2.08%
EBITDA Q/Q Growth
18.68% 2.79% 28.20% 3.72% -14.37% -1.65% 15.88% 4.29% 0.60% 0.33% -0.24%
EBIT Q/Q Growth
203.44% -1.78% 145.08% 11.04% -27.94% -3.86% 44.46% 10.74% 1.63% 1.93% -2.27%
NOPAT Q/Q Growth
574.45% 0.20% 280.15% -99.62% -27.71% -0.63% 18.30% 10.07% -0.79% 10.92% -16.00%
Net Income Q/Q Growth
278.73% -15.04% 431.68% -71.95% -15.93% 4.58% 16.21% 8.72% -0.81% 0.53% -13.75%
EPS Q/Q Growth
163.64% -40.54% 5,500.00% -77.08% -16.39% 1.41% 90.00% 0.00% -1.87% 0.00% -15.00%
Operating Cash Flow Q/Q Growth
-6.54% 0.20% 8.25% 12.48% -29.08% 16.97% 1.29% 10.75% 2.84% -23.51% 25.04%
Free Cash Flow Firm Q/Q Growth
29.44% 233.17% -4.26% -99.30% 1,385.88% -93.55% 0.91% 7.39% 328.87% -20.52% 8.92%
Invested Capital Q/Q Growth
-5.62% -7.33% 10.37% -3.95% -28.35% 0.46% 0.90% 0.94% -18.54% -15.58% -8.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
7.61% 8.32% 7.67% 7.06% 7.20% 10.98% 7.74% 7.56% 8.72% 9.72% 11.00%
EBITDA Margin
2.96% 3.92% 4.40% 4.23% 4.65% 9.45% 3.25% 3.62% 3.86% 3.64% 5.18%
Operating Margin
0.70% 0.86% 1.55% 1.43% 2.02% 5.82% 1.01% 1.93% 2.01% 1.72% 2.67%
EBIT Margin
0.71% 0.91% 1.57% 1.45% 2.04% 5.84% 1.02% 1.94% 2.03% 1.74% 2.68%
Profit (Net Income) Margin
0.51% 0.57% 1.11% 0.21% 0.84% 5.56% 0.61% 1.28% 0.97% 0.55% 1.14%
Tax Burden Percent
144.72% 104.41% 469.24% 208.75% 107.30% 107.99% 117.50% 98.89% 94.40% 118.05% 83.52%
Interest Burden Percent
49.86% 60.47% 15.03% 7.10% 38.42% 88.14% 50.25% 66.74% 50.77% 26.66% 50.99%
Effective Tax Rate
-44.72% -4.41% -369.24% -108.75% -7.30% -7.99% -17.50% 1.11% 5.60% -18.05% 16.48%
Return on Invested Capital (ROIC)
3.96% 2.48% 22.17% 11.12% 8.09% 21.08% 5.69% 11.20% 10.28% 10.99% 10.64%
ROIC Less NNEP Spread (ROIC-NNEP)
0.70% 1.07% -4.14% -2.02% 2.62% 18.41% 2.55% 7.20% 4.90% 2.93% 5.76%
Return on Net Nonoperating Assets (RNNOA)
1.03% 1.90% -10.35% -7.40% 24.50% 174.89% 20.36% 82.68% 67.24% 741.46% -97.05%
Return on Equity (ROE)
4.99% 4.38% 11.83% 3.72% 32.59% 195.97% 26.05% 93.88% 77.52% 752.45% -86.41%
Cash Return on Invested Capital (CROIC)
-34.82% 1.17% 21.75% 20.31% 26.32% 2.52% -25.61% 14.81% 15.99% 18.31% 28.80%
Operating Return on Assets (OROA)
2.18% 1.89% 3.50% 3.90% 4.93% 11.73% 3.21% 7.64% 7.29% 6.21% 9.45%
Return on Assets (ROA)
1.57% 1.19% 2.47% 0.58% 2.03% 11.16% 1.90% 5.04% 3.49% 1.96% 4.02%
Return on Common Equity (ROCE)
4.99% 4.38% 11.85% 3.73% 32.59% 195.97% 26.05% 75.79% 39.50% -6,400.96% -139.32%
Return on Equity Simple (ROE_SIMPLE)
4.26% 4.85% 13.53% 4.73% 0.00% 97.98% 38.29% 120.23% 1,416.43% -41.75% 0.00%
Net Operating Profit after Tax (NOPAT)
22 17 152 73 46 121 42 95 83 83 82
NOPAT Margin
1.01% 0.90% 7.26% 2.99% 2.16% 6.28% 1.19% 1.91% 1.90% 2.03% 2.23%
Net Nonoperating Expense Percent (NNEP)
3.26% 1.41% 26.31% 13.14% 5.47% 2.67% 3.14% 4.01% 5.38% 8.06% 4.87%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 11.50% 10.94% 11.68% 12.00%
Cost of Revenue to Revenue
92.39% 91.68% 92.33% 92.94% 92.83% 89.02% 92.26% 92.44% 91.28% 90.28% 89.00%
SG&A Expenses to Revenue
4.87% 4.56% 4.26% 3.27% 3.23% 5.79% 4.61% 4.03% 5.06% 6.26% 7.09%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.92% 7.46% 6.13% 5.63% 5.87% 5.16% 6.73% 5.63% 6.71% 8.00% 8.33%
Earnings before Interest and Taxes (EBIT)
16 17 33 35 44 113 37 97 89 71 98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
66 73 92 103 100 183 116 180 169 149 190
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.85 1.67 2.35 2.46 0.00 4.24 10.25 11.47 256.53 0.00 0.00
Price to Tangible Book Value (P/TBV)
2.17 7.21 65.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.10 0.20 0.19 0.11 0.18 0.24 0.16 0.12 0.18 0.20 0.21
Price to Earnings (P/E)
22.80 50.49 21.37 74.38 22.44 4.33 26.77 9.81 19.23 41.27 19.68
Dividend Yield
20.98% 25.98% 20.87% 27.70% 18.39% 16.87% 13.73% 13.15% 10.38% 9.77% 10.44%
Earnings Yield
4.39% 1.98% 4.68% 1.34% 4.46% 23.07% 3.74% 10.20% 5.20% 2.42% 5.08%
Enterprise Value to Invested Capital (EV/IC)
0.95 1.22 1.35 1.26 1.78 1.58 1.62 1.67 1.97 2.21 2.26
Enterprise Value to Revenue (EV/Rev)
0.29 0.45 0.44 0.32 0.43 0.51 0.39 0.28 0.35 0.39 0.43
Enterprise Value to EBITDA (EV/EBITDA)
9.69 11.40 10.10 7.65 9.30 5.44 11.97 7.73 9.16 10.81 8.32
Enterprise Value to EBIT (EV/EBIT)
40.24 49.19 28.30 22.37 21.19 8.81 38.00 14.41 17.46 22.62 16.07
Enterprise Value to NOPAT (EV/NOPAT)
28.51 49.59 6.11 10.83 19.99 8.19 32.83 14.65 18.66 19.37 19.36
Enterprise Value to Operating Cash Flow (EV/OCF)
9.91 10.51 10.45 8.82 12.85 9.52 14.60 8.62 13.25 18.38 17.25
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 104.83 6.23 5.93 6.14 68.60 0.00 11.08 11.99 11.63 7.15
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.53 2.12 3.11 4.70 0.00 4.83 14.53 9.77 24.62 -30.96 -10.85
Long-Term Debt to Equity
1.50 2.11 3.09 4.68 0.00 4.81 14.33 9.62 24.52 -30.82 -10.81
Financial Leverage
1.46 1.78 2.50 3.66 9.36 9.50 7.97 11.49 13.72 253.06 -16.84
Leverage Ratio
3.18 3.66 4.80 6.43 16.03 17.56 13.74 18.63 22.20 384.79 -21.48
Compound Leverage Factor
1.58 2.21 0.72 0.46 6.16 15.48 6.91 12.43 11.27 102.59 -10.95
Debt to Total Capital
60.47% 67.91% 75.68% 82.46% 100.00% 82.85% 93.56% 90.71% 96.10% 103.34% 110.15%
Short-Term Debt to Total Capital
1.12% 0.31% 0.41% 0.36% 0.46% 0.41% 1.25% 1.31% 0.39% 0.44% 0.49%
Long-Term Debt to Total Capital
59.35% 67.60% 75.26% 82.10% 99.54% 82.44% 92.31% 89.40% 95.70% 102.90% 109.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.02% -0.03% -0.05% 0.00% 0.00% 0.00% 0.00% 3.07% 3.52% 3.91% 4.27%
Common Equity to Total Capital
39.55% 32.13% 24.37% 17.54% 0.00% 17.15% 6.44% 6.22% 0.38% -7.24% -14.41%
Debt to EBITDA
6.23 6.38 5.78 5.04 5.38 2.90 7.06 4.30 4.47 5.14 4.12
Net Debt to EBITDA
6.22 6.36 5.73 5.01 5.36 2.90 6.99 4.21 4.44 5.12 4.10
Long-Term Debt to EBITDA
6.12 6.35 5.75 5.02 5.35 2.89 6.97 4.23 4.45 5.12 4.10
Debt to NOPAT
18.35 27.75 3.50 7.14 11.56 4.37 19.35 8.14 9.10 9.21 9.59
Net Debt to NOPAT
18.30 27.67 3.47 7.09 11.52 4.36 19.17 7.97 9.04 9.17 9.55
Long-Term Debt to NOPAT
18.01 27.63 3.48 7.10 11.51 4.34 19.10 8.02 9.07 9.17 9.54
Altman Z-Score
2.85 2.37 2.62 3.12 2.74 2.50 3.15 4.46 4.31 4.27 4.52
Noncontrolling Interest Sharing Ratio
-0.04% -0.08% -0.14% -0.11% 0.00% 0.00% 0.00% 19.28% 49.05% 950.69% -61.23%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.78 0.87 0.86 0.58 0.62 0.51 0.65 0.68 0.67 0.73 0.72
Quick Ratio
0.46 0.58 0.49 0.33 0.39 0.20 0.26 0.27 0.23 0.22 0.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-197 7.96 149 133 151 14 -191 125 129 139 221
Operating Cash Flow to CapEx
1,708.72% 439.04% 0.00% 1,268.58% 366.12% 0.00% 360.26% 948.53% 412.35% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-10.66 0.35 5.34 4.06 5.60 0.87 -10.47 3.91 2.96 2.65 4.59
Operating Cash Flow to Interest Expense
3.49 3.49 3.19 2.73 2.68 6.30 5.23 5.03 2.68 1.68 1.90
Operating Cash Flow Less CapEx to Interest Expense
3.28 2.70 3.73 2.52 1.95 6.76 3.78 4.50 2.03 1.85 3.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
3.05 2.09 2.23 2.70 2.42 2.01 3.13 3.93 3.60 3.57 3.52
Accounts Receivable Turnover
62.46 49.74 49.60 71.82 63.01 53.83 111.97 150.42 138.83 128.35 119.13
Inventory Turnover
147.93 118.62 136.75 155.67 196.41 116.69 95.23 98.32 80.36 64.06 53.10
Fixed Asset Turnover
4.37 2.86 3.08 3.68 3.54 3.40 5.40 6.70 6.12 6.02 6.08
Accounts Payable Turnover
55.21 39.96 36.44 38.21 34.54 27.05 45.80 57.50 48.83 46.00 42.99
Days Sales Outstanding (DSO)
5.84 7.34 7.36 5.08 5.79 6.78 3.26 2.43 2.63 2.84 3.06
Days Inventory Outstanding (DIO)
2.47 3.08 2.67 2.34 1.86 3.13 3.83 3.71 4.54 5.70 6.87
Days Payable Outstanding (DPO)
6.61 9.13 10.02 9.55 10.57 13.49 7.97 6.35 7.48 7.94 8.49
Cash Conversion Cycle (CCC)
1.70 1.28 0.01 -2.13 -2.92 -3.58 -0.88 -0.21 -0.30 0.61 1.45
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
676 685 687 627 522 629 863 832 786 730 697
Invested Capital Turnover
3.93 2.75 3.05 3.72 3.74 3.36 4.80 5.86 5.42 5.41 4.78
Increase / (Decrease) in Invested Capital
219 8.87 2.91 -60 -105 107 233 -31 -46 -56 -139
Enterprise Value (EV)
639 835 930 792 929 995 1,394 1,391 1,551 1,614 1,579
Market Capitalization
229 369 402 273 394 465 580 608 771 821 770
Book Value per Share
$8.09 $6.60 $5.04 $3.22 $0.00 $2.90 $1.49 $1.40 $0.08 ($1.41) ($2.68)
Tangible Book Value per Share
$3.18 $1.53 $0.18 ($1.07) ($3.88) ($1.90) ($4.17) ($4.23) ($5.05) ($6.06) ($6.91)
Total Capital
680 688 703 633 537 640 878 852 788 742 710
Total Debt
411 467 532 522 537 530 822 773 757 767 782
Total Long-Term Debt
404 465 529 519 535 527 811 762 754 764 778
Net Debt
410 466 528 518 536 529 814 757 752 764 779
Capital Expenditures (CapEx)
3.77 18 -15 7.08 20 -7.72 27 17 28 -9.06 -68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-10 -8.98 -14 -38 -43 -70 -54 -62 -54 -44 -44
Debt-free Net Working Capital (DFNWC)
-9.17 -7.63 -10 -35 -41 -69 -47 -46 -49 -41 -41
Net Working Capital (NWC)
-17 -9.73 -13 -38 -43 -72 -58 -57 -53 -44 -44
Net Nonoperating Expense (NNE)
11 6.12 129 68 28 14 21 31 41 61 40
Net Nonoperating Obligations (NNO)
407 464 516 516 522 520 806 753 755 755 769
Total Depreciation and Amortization (D&A)
50 56 59 68 56 70 80 83 80 78 92
Debt-free, Cash-free Net Working Capital to Revenue
-0.47% -0.48% -0.67% -1.57% -1.98% -3.62% -1.52% -1.24% -1.24% -1.08% -1.20%
Debt-free Net Working Capital to Revenue
-0.41% -0.41% -0.48% -1.44% -1.90% -3.60% -1.30% -0.92% -1.13% -0.99% -1.11%
Net Working Capital to Revenue
-0.75% -0.52% -0.62% -1.54% -2.01% -3.73% -1.61% -1.15% -1.20% -1.07% -1.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.35 $0.22 $0.56 $0.11 $0.00 $2.87 $0.57 $1.63 $1.06 $0.52 $1.03
Adjusted Weighted Average Basic Shares Outstanding
21.46M 32.16M 33.84M 34.35M 0.00 37.37M 37.88M 37.92M 37.96M 38.03M 38.10M
Adjusted Diluted Earnings per Share
$0.35 $0.22 $0.56 $0.11 $0.00 $2.87 $0.57 $1.63 $1.05 $0.52 $1.02
Adjusted Weighted Average Diluted Shares Outstanding
33.11M 33.52M 33.86M 34.35M 0.00 37.87M 37.88M 38.06M 38.12M 38.17M 38.25M
Adjusted Basic & Diluted Earnings per Share
$0.35 $0.00 $0.00 $0.11 $0.00 $2.87 $0.57 $1.63 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
33.11M 33.37M 33.84M 34.35M 0.00 37.87M 37.88M 37.92M 37.98M 38.06M 38.14M
Normalized Net Operating Profit after Tax (NOPAT)
8.94 11 23 25 30 22 24 94 79 46 45
Normalized NOPAT Margin
0.40% 0.60% 1.08% 1.00% 1.41% 1.14% 0.67% 1.89% 1.79% 1.12% 1.22%
Pre Tax Income Margin
0.36% 0.55% 0.24% 0.10% 0.78% 5.15% 0.51% 1.30% 1.03% 0.46% 1.37%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.86 0.75 1.18 1.08 1.62 6.81 2.01 3.01 2.03 1.36 2.04
NOPAT to Interest Expense
1.21 0.74 5.45 2.22 1.72 7.32 2.33 2.96 1.90 1.59 1.69
EBIT Less CapEx to Interest Expense
0.65 -0.05 1.72 0.86 0.89 7.27 0.56 2.48 1.38 1.54 3.46
NOPAT Less CapEx to Interest Expense
1.01 -0.06 5.99 2.01 0.99 7.78 0.87 2.43 1.25 1.77 3.11
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
576.64% 779.82% 380.68% 1,471.56% 403.63% 72.52% 367.38% 125.33% 187.72% 362.65% 195.34%
Augmented Payout Ratio
608.07% 810.17% 380.68% 1,471.56% 403.63% 72.52% 367.38% 125.33% 187.72% 362.65% 195.34%

Quarterly Metrics And Ratios for CrossAmerica Partners

This table displays calculated financial ratios and metrics derived from CrossAmerica Partners' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 38,135,078.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 38,135,078.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.26
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.05% -9.79% -7.34% -1.05% -10.81% -6.94% -8.40% -15.13% -9.94% -8.25% -2.39%
EBITDA Growth
-28.94% 2.23% -79.36% -1.10% 10.52% 1.06% 351.31% 38.47% 0.50% -0.95% 43.34%
EBIT Growth
-38.83% 5.54% -236.55% 1.14% 12.23% 4.99% 116.65% 46.93% 3.47% -8.02% 1,021.87%
NOPAT Growth
-38.06% -1.08% -243.19% 6.09% 2.50% 16.74% 115.34% 45.01% 4.92% -45.03% 1,273.66%
Net Income Growth
-55.45% -2.03% -1,691.62% -14.53% -12.89% 0.70% 59.44% 102.58% 26.90% -39.55% 249.81%
EPS Growth
-56.34% -4.55% -1,100.00% -13.89% -12.90% 0.00% 58.33% 106.45% 25.93% -42.86% 230.00%
Operating Cash Flow Growth
-55.81% 9.29% -49.59% -19.08% 32.22% -70.84% 158.72% -21.65% -41.91% 164.91% 85.27%
Free Cash Flow Firm Growth
-281.53% 26.57% -86.64% 201.41% 202.43% 18.81% -173.19% -85.57% 5.91% 930.97% 579.11%
Invested Capital Growth
17.02% -5.56% -4.57% -20.64% -10.32% -7.06% 2.84% 0.43% -12.21% -16.65% -10.00%
Revenue Q/Q Growth
5.64% -16.14% -7.21% 20.37% -4.78% -12.50% -8.66% 11.53% 1.03% -10.86% -2.82%
EBITDA Q/Q Growth
-8.15% 6.11% -86.24% 637.61% 2.64% -2.97% -38.56% 126.32% -25.51% -4.37% -11.09%
EBIT Q/Q Growth
-13.20% 11.66% -147.12% 321.44% -3.68% 4.45% -92.52% 1,853.68% -32.17% -7.14% -8.83%
NOPAT Q/Q Growth
-7.66% 25.59% -133.71% 371.37% -10.78% 43.04% -95.57% 2,465.46% -35.45% -25.06% 10.69%
Net Income Q/Q Growth
-15.44% 36.21% -204.76% 170.83% -13.81% 57.46% -142.20% 453.73% -46.01% -24.99% 4.58%
EPS Q/Q Growth
-13.89% 35.48% -214.29% 164.58% -12.90% 55.56% -147.62% 420.00% -46.88% -29.41% 8.33%
Operating Cash Flow Q/Q Growth
-11.19% 20.07% -84.73% 397.03% 45.12% -73.52% 35.44% 50.53% 7.59% 20.78% -5.28%
Free Cash Flow Firm Q/Q Growth
-258.30% 161.75% -61.43% 691.26% -46.20% -28.38% -124.01% 256.01% 294.81% 21.59% -36.03%
Invested Capital Q/Q Growth
-1.11% -18.54% 0.28% -1.67% 11.76% -15.58% 10.85% -3.97% -2.31% -8.22% 4.53%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
8.30% 10.06% 8.64% 9.24% 10.31% 10.69% 10.41% 10.50% 10.78% 12.37% 11.60%
EBITDA Margin
3.63% 4.59% 0.68% 4.17% 4.50% 4.99% 3.35% 6.80% 5.02% 5.38% 4.92%
Operating Margin
2.00% 2.66% -1.39% 2.49% 2.51% 3.00% 0.23% 4.31% 2.89% 3.01% 2.82%
EBIT Margin
2.01% 2.68% -1.36% 2.50% 2.53% 3.02% 0.25% 4.33% 2.91% 3.03% 2.84%
Profit (Net Income) Margin
1.02% 1.65% -1.86% 1.10% 0.99% 1.79% -0.83% 2.62% 1.40% 1.18% 1.27%
Tax Burden Percent
89.33% 100.47% 75.16% 87.95% 81.59% 111.62% 66.41% 86.60% 82.59% 66.69% 81.01%
Interest Burden Percent
56.58% 61.37% 182.38% 49.86% 48.09% 52.99% -502.72% 69.81% 58.26% 58.28% 55.03%
Effective Tax Rate
10.67% -0.47% 0.00% 12.05% 18.41% -11.62% 0.00% 13.40% 17.41% 33.31% 18.99%
Return on Invested Capital (ROIC)
8.96% 14.47% -5.19% 10.75% 9.33% 18.11% 0.82% 18.53% 10.99% 9.59% 10.82%
ROIC Less NNEP Spread (ROIC-NNEP)
7.84% 13.10% -6.27% 9.29% 8.08% 16.15% -0.21% 17.19% 9.87% 8.70% 9.80%
Return on Net Nonoperating Assets (RNNOA)
98.44% 179.82% -181.64% 333.65% 785.74% 4,086.99% 6.02% -445.21% -182.96% -146.54% -121.61%
Return on Equity (ROE)
107.40% 194.30% -186.83% 344.40% 795.08% 4,105.09% 6.84% -426.69% -171.97% -136.95% -110.79%
Cash Return on Invested Capital (CROIC)
-6.32% 15.99% 13.39% 31.56% 19.09% 18.31% 8.34% 12.06% 24.96% 28.80% 23.04%
Operating Return on Assets (OROA)
7.34% 9.63% -4.88% 9.02% 8.98% 10.78% 0.88% 15.19% 10.21% 10.66% 9.90%
Return on Assets (ROA)
3.71% 5.93% -6.68% 3.96% 3.52% 6.37% -2.93% 9.18% 4.91% 4.14% 4.41%
Return on Common Equity (ROCE)
64.56% 98.99% 4.84% -64.70% -1,573.03% -34,921.49% 13.67% -833.39% -279.84% -220.81% -160.63%
Return on Equity Simple (ROE_SIMPLE)
193.31% 0.00% -86.14% -64.21% -37.83% 0.00% -38.24% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
22 27 -9.13 25 22 32 1.40 36 23 17 19
NOPAT Margin
1.78% 2.67% -0.97% 2.19% 2.05% 3.35% 0.16% 3.74% 2.39% 2.01% 2.29%
Net Nonoperating Expense Percent (NNEP)
1.12% 1.37% 1.08% 1.45% 1.26% 1.96% 1.03% 1.33% 1.12% 0.88% 1.03%
Return On Investment Capital (ROIC_SIMPLE)
- 3.56% - - - 4.43% 0.17% 4.66% 3.13% 2.56% 2.70%
Cost of Revenue to Revenue
91.70% 89.94% 91.36% 90.76% 89.69% 89.31% 89.59% 89.50% 89.22% 87.63% 88.40%
SG&A Expenses to Revenue
4.75% 5.49% 6.25% 5.62% 6.31% 7.00% 7.72% 6.71% 6.59% 7.46% 7.48%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.31% 7.40% 10.03% 6.76% 7.80% 7.69% 10.18% 6.19% 7.89% 9.36% 8.78%
Earnings before Interest and Taxes (EBIT)
24 27 -13 28 27 29 2.13 42 28 26 24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
44 47 6.41 47 49 47 29 65 49 47 41
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
33.05 256.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.16 0.18 0.20 0.17 0.19 0.20 0.23 0.21 0.21 0.21 0.21
Price to Earnings (P/E)
18.12 19.23 36.02 34.66 39.03 41.27 30.20 18.75 17.13 19.68 13.65
Dividend Yield
10.91% 10.38% 9.43% 10.86% 10.39% 9.77% 8.73% 10.29% 10.24% 10.44% 10.36%
Earnings Yield
5.52% 5.20% 2.78% 2.88% 2.56% 2.42% 3.31% 5.33% 5.84% 5.08% 7.32%
Enterprise Value to Invested Capital (EV/IC)
1.74 1.97 2.12 2.01 1.97 2.21 2.29 2.17 2.16 2.26 2.23
Enterprise Value to Revenue (EV/Rev)
0.37 0.35 0.39 0.36 0.41 0.39 0.46 0.44 0.44 0.43 0.45
Enterprise Value to EBITDA (EV/EBITDA)
9.97 9.16 11.52 10.77 11.48 10.81 10.79 8.86 8.63 8.32 8.02
Enterprise Value to EBIT (EV/EBIT)
19.19 17.46 25.00 23.17 24.40 22.62 21.48 16.90 16.34 16.07 13.52
Enterprise Value to NOPAT (EV/NOPAT)
20.02 18.66 23.73 20.79 22.74 19.37 20.83 17.37 16.91 19.36 16.86
Enterprise Value to Operating Cash Flow (EV/OCF)
14.74 13.25 14.97 14.85 14.88 18.38 19.10 18.55 22.44 17.25 15.55
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 11.99 15.44 5.62 9.78 11.63 27.81 17.98 8.10 7.15 9.15
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
18.70 24.62 -439.43 -96.57 -29.81 -30.96 -16.24 -15.80 -13.45 -10.85 -10.48
Long-Term Debt to Equity
17.93 24.52 -437.71 -96.18 -28.57 -30.82 -15.55 -15.11 -12.84 -10.81 -10.35
Financial Leverage
12.56 13.72 28.99 35.90 97.30 253.06 -28.46 -25.89 -18.53 -16.84 -12.41
Leverage Ratio
18.67 22.20 44.70 50.24 126.10 384.79 -38.97 -35.19 -22.98 -21.48 -15.50
Compound Leverage Factor
10.56 13.62 81.52 25.05 60.64 203.89 195.93 -24.56 -13.39 -12.52 -8.53
Debt to Total Capital
94.92% 96.10% 100.23% 101.05% 103.47% 103.34% 106.56% 106.76% 108.03% 110.15% 110.55%
Short-Term Debt to Total Capital
3.92% 0.39% 0.39% 0.41% 4.31% 0.44% 4.48% 4.67% 4.88% 0.49% 1.32%
Long-Term Debt to Total Capital
91.00% 95.70% 99.84% 100.64% 99.16% 102.90% 102.08% 102.09% 103.15% 109.66% 109.23%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.79% 3.52% 3.56% 3.72% 3.20% 3.91% 3.46% 3.79% 3.86% 4.27% 4.17%
Common Equity to Total Capital
2.29% 0.38% -3.79% -4.77% -6.67% -7.24% -10.02% -10.54% -11.89% -14.41% -14.71%
Debt to EBITDA
5.48 4.47 5.52 5.48 6.15 5.14 5.32 4.50 4.38 4.12 4.06
Net Debt to EBITDA
5.45 4.44 5.48 5.44 6.10 5.12 5.29 4.45 4.35 4.10 4.03
Long-Term Debt to EBITDA
5.25 4.45 5.50 5.46 5.90 5.12 5.10 4.31 4.18 4.10 4.02
Debt to NOPAT
11.01 9.10 11.37 10.58 12.19 9.21 10.28 8.83 8.58 9.59 8.54
Net Debt to NOPAT
10.94 9.04 11.28 10.50 12.08 9.17 10.21 8.73 8.52 9.55 8.47
Long-Term Debt to NOPAT
10.55 9.07 11.33 10.53 11.68 9.17 9.85 8.44 8.19 9.54 8.44
Altman Z-Score
4.08 4.14 4.01 4.11 4.12 4.15 4.17 4.28 4.23 4.28 4.09
Noncontrolling Interest Sharing Ratio
39.89% 49.05% 102.59% 118.79% 297.85% 950.69% -99.85% -95.32% -62.72% -61.23% -44.99%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.70 0.67 0.77 0.76 0.73 0.73 0.93 0.77 0.71 0.72 0.75
Quick Ratio
0.25 0.23 0.27 0.27 0.23 0.22 0.22 0.26 0.25 0.21 0.23
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-119 73 29 226 122 87 -21 33 129 157 100
Operating Cash Flow to CapEx
320.40% 325.67% 95.27% 0.00% 8,667.15% 0.00% 1,099.12% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-11.25 6.99 2.71 15.92 8.59 6.50 -1.63 2.60 10.93 14.32 9.32
Operating Cash Flow to Interest Expense
3.00 3.63 0.55 2.03 2.96 0.83 1.17 1.80 2.07 2.69 2.59
Operating Cash Flow Less CapEx to Interest Expense
2.07 2.52 -0.03 2.42 2.93 1.59 1.06 5.95 3.37 2.89 3.49
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
3.65 3.60 3.59 3.61 3.55 3.57 3.55 3.51 3.51 3.52 3.49
Accounts Receivable Turnover
122.18 138.83 132.26 115.55 116.28 128.35 122.73 106.52 111.50 119.13 118.76
Inventory Turnover
81.75 80.36 74.19 67.70 65.79 64.06 60.75 56.19 54.85 53.10 51.31
Fixed Asset Turnover
6.23 6.12 6.12 6.17 6.08 6.02 6.19 6.05 6.06 6.08 6.09
Accounts Payable Turnover
46.05 48.83 51.15 46.38 41.95 46.00 45.26 42.25 39.76 42.99 38.98
Days Sales Outstanding (DSO)
2.99 2.63 2.76 3.16 3.14 2.84 2.97 3.43 3.27 3.06 3.07
Days Inventory Outstanding (DIO)
4.46 4.54 4.92 5.39 5.55 5.70 6.01 6.50 6.66 6.87 7.11
Days Payable Outstanding (DPO)
7.93 7.48 7.14 7.87 8.70 7.94 8.06 8.64 9.18 8.49 9.36
Cash Conversion Cycle (CCC)
-0.47 -0.30 0.54 0.68 -0.02 0.61 0.92 1.28 0.75 1.45 0.82
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
965 786 787 774 865 730 810 777 759 697 729
Invested Capital Turnover
5.03 5.42 5.35 4.91 4.56 5.41 5.03 4.96 4.60 4.78 4.74
Increase / (Decrease) in Invested Capital
140 -46 -38 -201 -100 -56 22 3.30 -106 -139 -81
Enterprise Value (EV)
1,678 1,551 1,667 1,552 1,708 1,614 1,853 1,683 1,642 1,579 1,622
Market Capitalization
734 771 846 739 772 821 915 807 785 770 776
Book Value per Share
$0.59 $0.08 ($0.80) ($0.98) ($1.55) ($1.41) ($2.26) ($2.22) ($2.41) ($2.68) ($2.87)
Tangible Book Value per Share
($4.63) ($5.05) ($5.79) ($5.85) ($6.31) ($6.06) ($6.79) ($6.64) ($6.72) ($6.91) ($7.00)
Total Capital
972 788 797 782 885 742 858 801 771 710 744
Total Debt
922 757 799 790 915 767 915 855 833 782 822
Total Long-Term Debt
884 754 796 787 877 764 876 818 796 778 812
Net Debt
917 752 793 784 907 764 908 846 828 779 815
Capital Expenditures (CapEx)
9.90 12 6.11 -5.43 0.48 -10 1.37 -52 -15 -2.19 -9.62
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-22 -54 -40 -42 -17 -44 19 -9.11 -15 -44 -40
Debt-free Net Working Capital (DFNWC)
-16 -49 -33 -37 -8.98 -41 26 0.61 -9.24 -41 -33
Net Working Capital (NWC)
-54 -53 -37 -40 -47 -44 -12 -37 -47 -44 -43
Net Nonoperating Expense (NNE)
9.28 10 8.41 12 11 15 8.52 11 9.61 7.19 8.58
Net Nonoperating Obligations (NNO)
915 755 789 782 896 755 866 832 821 769 807
Total Depreciation and Amortization (D&A)
20 19 19 19 21 19 27 24 21 20 18
Debt-free, Cash-free Net Working Capital to Revenue
-0.48% -1.24% -0.92% -0.98% -0.40% -1.08% 0.48% -0.24% -0.40% -1.20% -1.10%
Debt-free Net Working Capital to Revenue
-0.35% -1.13% -0.78% -0.85% -0.22% -0.99% 0.65% 0.02% -0.25% -1.11% -0.90%
Net Working Capital to Revenue
-1.20% -1.20% -0.85% -0.93% -1.13% -1.07% -0.30% -0.96% -1.25% -1.21% -1.17%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.31 $0.42 ($0.48) $0.31 $0.27 $0.42 ($0.20) $0.64 $0.34 $0.25 $0.26
Adjusted Weighted Average Basic Shares Outstanding
37.97M 37.96M 37.99M 38.03M 38.04M 38.03M 38.07M 38.10M 38.11M 38.10M 38.14M
Adjusted Diluted Earnings per Share
$0.31 $0.42 ($0.48) $0.31 $0.27 $0.42 ($0.20) $0.64 $0.34 $0.24 $0.26
Adjusted Weighted Average Diluted Shares Outstanding
38.14M 38.12M 37.99M 38.20M 38.20M 38.17M 38.07M 39.55M 38.27M 38.25M 38.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
37.97M 37.98M 38.03M 38.05M 38.05M 38.06M 38.10M 38.12M 38.12M 38.14M 38.15M
Normalized Net Operating Profit after Tax (NOPAT)
21 19 2.63 20 18 12 -2.13 11 17 15 14
Normalized NOPAT Margin
1.76% 1.89% 0.28% 1.75% 1.69% 1.25% -0.25% 1.18% 1.76% 1.74% 1.70%
Pre Tax Income Margin
1.14% 1.64% -2.48% 1.25% 1.22% 1.60% -1.24% 3.02% 1.69% 1.76% 1.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.30 2.59 -1.21 1.99 1.93 2.13 0.17 3.31 2.40 2.40 2.22
NOPAT to Interest Expense
2.04 2.58 -0.87 1.74 1.56 2.36 0.11 2.86 1.97 1.59 1.79
EBIT Less CapEx to Interest Expense
1.37 1.47 -1.79 2.38 1.89 2.89 0.06 7.46 3.70 2.60 3.12
NOPAT Less CapEx to Interest Expense
1.10 1.47 -1.45 2.13 1.53 3.12 0.00 7.01 3.27 1.79 2.68
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
188.23% 187.72% 307.27% 334.11% 360.39% 362.65% 247.81% 178.68% 168.06% 195.34% 137.15%
Augmented Payout Ratio
188.23% 187.72% 307.27% 334.11% 360.39% 362.65% 247.81% 178.68% 168.06% 195.34% 137.15%

Financials Breakdown Chart

Key Financial Trends

MarketBeat's quick take on CrossAmerica Partners (CAPL) over the last four fiscal years shows a mix of margin improvement, steady cash generation, and leverage reduction, but ongoing top-line pressure and cost containment remain key questions for investors.

  • Gross margin improvement in late 2025: Q4 2025 gross margin was about 12.3% (107.131M gross profit on 866.287M revenue), up from roughly 10.7% in Q4 2024, signaling improved profitability on product sales.
  • Operating cash flow trending higher in 2025: Net cash from continuing operating activities rose to 29.431M in Q4 2025, with prior 2025 quarters showing 24.368M (Q3 2025) and 22.650M (Q2 2025), signaling stronger cash generation from core operations.
  • Stable, recurring dividends: CAPL maintained a quarterly dividend of 0.525 per share across 2025 (and surrounding periods), providing a predictable income stream for investors.
  • Balance sheet de-leveraging in 2025: Long-term debt declined from about 769.2M in Q1 2025 to 700.8M in Q3 2025, indicating progress in reducing leverage.
  • Consistent profitability to common shareholders in 2025: Net income attributable to common shareholders was positive in several 2025 quarters (Q4 2025: 9.51M; Q3 2025: 12.89M; Q2 2025: 24.49M), suggesting ongoing earnings generation.
  • Free cash flow potential in Q4 2025: Approximate quarterly free cash flow was about 22.36M (OCF 29.431M minus capex 7.072M), highlighting available cash after sustaining investments.
  • Sizable asset base supports operations: PPE net around 569M (Q3 2025: 568.89M), underscoring a substantial fixed asset base for operations.
  • Top-line pressure persists (historical trend): Revenue declined from about 1.124B in Q4 2022 to about 0.866B in Q4 2025, indicating ongoing top-line pressure that investors should monitor.
  • Moderate, steady capex footprint: 2025 quarterly capex ranged roughly 6.7M–11.8M (e.g., 7.07M in Q4 2025; 6.70M in Q3 2025; 11.84M in Q2 2025; 10.11M in Q1 2025), suggesting limited growth-oriented investment.
  • Margin compression from rising SG&A in Q4 2025: SG&A climbed to 64.59M in Q4 2025, which, given the revenue base, implies a higher cost ratio (about 7.5% of revenue) and pressures on overall margins.
05/09/26 06:51 AM ETAI Generated. May Contain Errors.

CrossAmerica Partners Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CrossAmerica Partners' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CrossAmerica Partners' net income appears to be on an upward trend, with a most recent value of $41.83 million in 2025, rising from $11.46 million in 2015. The previous period was $22.45 million in 2024. See CrossAmerica Partners' forecast for analyst expectations on what's next for the company.

CrossAmerica Partners' total operating income in 2025 was $97.65 million, based on the following breakdown:
  • Total Gross Profit: $402.71 million
  • Total Operating Expenses: $305.06 million

Over the last 10 years, CrossAmerica Partners' total revenue changed from $2.23 billion in 2015 to $3.66 billion in 2025, a change of 64.5%.

CrossAmerica Partners' total liabilities were at $1.04 billion at the end of 2025, a 9.0% decrease from 2024, and a 75.0% increase since 2015.

In the past 10 years, CrossAmerica Partners' cash and equivalents has ranged from $513 thousand in 2020 to $16.05 million in 2022, and is currently $3.14 million as of their latest financial filing in 2025.

Over the last 10 years, CrossAmerica Partners' book value per share changed from 8.09 in 2015 to -2.68 in 2025, a change of -133.2%.



Financial statements for NYSE:CAPL last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners